APP and Alzheimer disease: At three months, the well-studied AD chimeric APP(swe)/PS1(ΔE9) (AD-Tg) mouse model have mitochondrial oxygen consumption rate (OCR) deficits [14] that precede amyloid deposition and plaque formation in brain [33].